Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Gastrointestinal Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1653063A details a safer gastrointestinal prokinetic intermediate. Discover cost-effective synthesis routes and supply chain advantages for high-purity production.
Patent CN107674023A reveals a cost-effective Rebamipide synthesis route using glycine methyl ester, offering significant supply chain and manufacturing advantages.
Novel cyclohexanone-based process for imidazopyridines offers high yield and scalability for gastric acid inhibitors, ensuring cost reduction in API manufacturing.
Advanced preparation method for Gefarnate using mild Wittig chemistry. Enhances purity and yield for pharmaceutical intermediates while reducing industrial processing costs.
Patent CN108976216B reveals a green, scalable route for Prucalopride intermediates, eliminating toxic reagents and ensuring high purity for global supply chains.
Patent CN1452621A details a novel cyclohexanone-based route for substituted imidazopyridines, offering superior yields and scalability for gastric acid inhibitor intermediates.
Novel recrystallization method removes persistent bromo impurities, ensuring high purity Prucalopride Succinate for reliable pharmaceutical manufacturing and supply chain stability.